Bardy Diagnostics is a developer of a cardiac monitor and arrhythmia detection device. The company has created a new, state-of-the-art heart monitor known as Carnation Ambulatory Monitor (CAM) that can be worn comfortably and discreetly for up to 7 days. Unlike many other heart monitors, CAM can be worn during exercise or while showering. Its unique, narrow, hourglass shape makes it especially advantageous for the female anatomy. It is also designed to be comfortable for women to wear, with its narrow, hourglass shape. Bardy Diagnostics uses his expertise to develop cardiac monitoring solutions that help physicians obtain more accurate information about actionable events in the hopes of saving lives. The company's mission is to improve clinical management and outcomes for patients and their physicians by employing innovative P-wave centric ECG detection into patient-friendly technologies that result in greater patient compliance and more confident physician diagnoses. Bardy Diagnostics was founded in 2013 and is headquartered in Seattle, Washington, USA.

Cardiac Pacemakers, Inc.(CPI), doing business as Guidant Cardiac Rhythm Management, manufactured implantable cardiac rhythm management devices, such as pacemakers and defibrillators. It also sold insulin pumps controlled by microprocessors and various equipments to regulate heart rhythm. In addition, Cardiac Pacemakers, Inc. developed therapies for the treatment of irregular heartbeats. The company was founded in 1971 and is based in St. Paul, Minnesota. Cardiac Pacemakers, Inc. operates as a subsidiary of Boston Scientific Corporation.

Medicomp, Inc. provides cardiac monitoring systems. The firm also offers cardiac, event, holter, and pacemaker monitoring solutions. The company was founded in 1981 and is headquartered in Melbourne, FL.

Manufactures auto injectors, syringes

Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN.

iRhythm Technologies, Inc. engages in the development of monitoring and diagnostic solutions for detection of cardiac arrhythmias. It offers Zio XT, is a wearable patch-based biosensor, which continuously records and stores ECG data from every patient heartbeat for up to 14 consecutive days, and Zio AT, which provides ECG data but also provides physicians with actionable notifications during the wear period. The company was founded by Uday N. Kumar in September 2006 and is headquartered in San Francisco, CA.

Heska Corporation manufactures, develops and sells advanced veterinary diagnostic and specialty healthcare products through its two business segments: North America and International. Both segments include Point of Care Lab testing instruments and consumables, digital imaging products, software and services, data services, allergy testing and immunotherapy, and single-use offerings such as in-clinic diagnostic tests and heartworm preventive products. The North America segment also includes private label vaccine and pharmaceutical production under third-party agreements and channels, primarily for herd animal health.

Part of Cornhill Corp. LLP, Picker International, Inc. is an American company that manufactures heating equipment.

HeartBeam, Inc. is a development stage company, which engages in cardiovascular diagnostic technology. Its electrocardiogram (ECG) collection device provides physicians with cardiac diagnostic information for a patient that is outside of a medical institution. The device sends ECG signals to the patient's smartphone and on to a cloud-based software expert system. The company was founded by Branislav Vajdic in 2015 and is headquartered in Santa Clara, CA.

RDS Corp. is a private company headquartered in Japan that distributes lighting equipments; provides electronic equipment repairing services.

Cardiac Science extends lives by providing the public and healthcare professionals with life-saving devices. Cardiac Science are committed to eliminating needless delays between sudden cardiac arrest (SCA) and life-saving defibrillation by ensuring automated external defibrillators (AEDs) are accessible and simple to use. Cardiac Science innovative, patented Powerheart:registered: AEDs provide assistance to SCA victims in all walks of life.Cardiac Science designs, manufactures, and markets Powerheart:registered: automated external defibrillators (AEDs) and related services that facilitate successful deployments. Cardiac Science growing list of AED placements include today's Fortune 500:registered: businesses, physician offices, schools, restaurants, malls, airports, sports fields, and other public places to combat sudden cardiac arrest (SCA), the leading cause of the death in the United States.

Pacesetter, Inc., a subsidiary of Abbott Laboratories, is a company headquartered in the United States that manufactures, and distributes cardiovascular and implantable neuro stimulation medical devices.

SentinHealth is a life science business that creates integrated care solutions for tracking and avoiding the worsening of chronic illnesses. It is a MedTech/AI business with a focus on integrated care solutions for tracking and preventing the progress of serious chronic conditions. They are motivated by the unmet demand of severe patients who need lifetime automated monitoring. Their telemonitoring system consists of an implant that is linked to the cloud and produces daily health status updates and forecasting information.

Corventis is committed to improving clinical outcomes and lowering healthcare costs by enabling the early detection of cardiovascular events while allowing patients to maintain an active lifestyle.

Optiscan Pty Ltd. develops microscopic imaging technologies for medical markets. The company was founded in 1994 and is headquartered in Melbourne, Australia.

Angel Medical Systems develops cardiac medical devices for patients in Brazil. It offers AngelMed Guardian system, an implantable cardiac monitoring and alerting system, which detects and warns patients of acute episodes of cardiac ischemia related to the progression of coronary artery disease and thrombotic coronary occlusion caused by vulnerable plaque ruptures. The company’s AngelMed Guardian System components include an internal implantable device that is designed to detect, analyze, and record crucial heart signal data; vibrate to alert patients of cardiac events, and track ST deviations vs. heart rate for up to six months. Its AngelMed Guardian System components also include an external telemetry device; and a programmer, which aids physicians in evaluating heart signals. The company was incorporated in 2001 and is based in Shrewsbury, New Jersey.

Many of our team have worked together on different projects and in different companies over the last 30-plus years. We are experienced technology, medical, health care and biotech professionals, with long, successful histories in Silicon Valley and elsewhere.